Phio Pharmaceuticals Corp (PHIO)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $9.21M
Last updated: Nov 17, 2026 at 11:00 AM ET
Phio Pharmaceuticals Corp (PHIO) Earnings: Report Dates and Results
Phio Pharmaceuticals (PHIO) is expected to report earnings on Mar 3, 2027. In the quarter ended Sep 30, 2026, Phio Pharmaceuticals reported EPS of -$0.36, in line with the -$0.36 estimate. It beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
PHIO has an expected report date of Mar 3, 2027.
Earnings History
Of the 34 quarters below that had an estimate, PHIO beat 18, missed 10 and matched 6. The widest gap in the table came in the quarter ended Sep 30, 2022, when EPS landed 172.22% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.36 | -$0.36 | -$0.37 - -$0.35 | 0.00% | In line | N/A | 2 | 0 up, 2 down | Nov 5, 2026 | N/A |
| Jun 30, 2026 | -$0.36 | -$0.36 | -$0.37 - -$0.35 | 0.00% | In line | N/A | 2 | 0 up, 2 down | Aug 6, 2026 | N/A |
| Mar 31, 2026 | -$0.34 | -$0.23 | -$0.24 - -$0.23 | -47.83% | Miss | N/A | 2 | 1 up, 0 down | May 7, 2026 | N/A |
| Dec 31, 2025 | -$0.15 | -$0.47 | -$0.47 - -$0.47 | +68.09% | Beat | N/A | 1 | 0 up, 0 down | Mar 5, 2026 | N/A |
| Sep 30, 2025 | -$0.44 | -$0.44 | -$0.44 - -$0.44 | 0.00% | In line | N/A | 1 | 0 up, 0 down | Nov 13, 2025 | N/A |
| Jun 30, 2025 | -$0.45 | -$0.36 | N/A | -25.00% | Miss | N/A | N/A | 0 up, 0 down | Aug 14, 2025 | N/A |
| Mar 31, 2025 | -$0.41 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 15, 2025 | N/A |
| Dec 31, 2024 | -$0.85 | -$1.23 | N/A | +30.89% | Beat | N/A | N/A | 0 up, 0 down | Mar 31, 2025 | $70000 |
| Sep 30, 2024 | -$1.54 | -$4.14 | N/A | +62.80% | Beat | N/A | N/A | 0 up, 0 down | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$3.62 | -$4.59 | -$4.59 - -$4.59 | +21.13% | Beat | N/A | 1 | 0 up, 0 down | Aug 14, 2024 | N/A |
| Mar 31, 2024 | -$1.53 | -$1.30 | N/A | -17.70% | Miss | N/A | N/A | 0 up, 0 down | Apr 1, 2024 | N/A |
| Dec 31, 2023 | -$0.85 | -$1.30 | -$1.30 - -$1.30 | +34.62% | Beat | N/A | 1 | 0 up, 0 down | Mar 20, 2024 | $6000 |
| Sep 30, 2023 | -$10.26 | -$12.87 | N/A | +20.28% | Beat | N/A | N/A | N/A | Nov 9, 2023 | N/A |
| Jun 30, 2023 | -$1.47 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | Aug 10, 2023 | N/A |
| Mar 31, 2023 | -$3.15 | N/A | N/A | N/A | N/A | N/A | N/A | 0 up, 0 down | May 11, 2023 | N/A |
| Dec 31, 2022 | -$21.78 | -$29.16 | N/A | +25.31% | Beat | N/A | 1 | 0 up, 0 down | Mar 22, 2023 | N/A |
| Sep 30, 2022 | -$28.08 | $38.88 | N/A | -172.22% | Miss | N/A | 1 | 0 up, 0 down | Nov 10, 2022 | N/A |
| Jun 30, 2022 | -$20.52 | -$33.48 | N/A | +38.71% | Beat | N/A | N/A | 0 up, 0 down | Aug 11, 2022 | N/A |
| Mar 31, 2022 | -$20.52 | -$32.40 | N/A | +36.67% | Beat | N/A | 1 | 0 up, 0 down | May 12, 2022 | N/A |
| Dec 31, 2021 | -$3.24 | -$3.84 | -$3.84 - -$3.84 | +15.63% | Beat | N/A | 1 | N/A | Mar 22, 2022 | N/A |
| Sep 30, 2021 | -$30.24 | -$27.00 | N/A | -12.00% | Miss | N/A | 1 | 0 up, 0 down | Nov 10, 2021 | N/A |
| Jun 30, 2021 | -$21.60 | -$28.08 | N/A | +23.08% | Beat | N/A | 1 | N/A | Aug 12, 2021 | N/A |
| Mar 31, 2021 | -$0.32 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 13, 2021 | N/A |
| Dec 31, 2020 | -$44.28 | -$45.36 | N/A | +2.38% | Beat | N/A | N/A | N/A | Mar 25, 2021 | N/A |
| Sep 30, 2020 | -$43.20 | -$40.50 | -$48.62 - -$32.42 | -6.67% | Miss | N/A | 2 | N/A | Nov 10, 2020 | N/A |
| Jun 30, 2020 | -$36.72 | -$69.66 | N/A | +47.29% | Beat | N/A | N/A | N/A | Aug 12, 2020 | N/A |
| Mar 31, 2020 | -$1.33 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 12, 2020 | N/A |
| Dec 31, 2019 | -$543.24 | -$475.20 | N/A | -14.32% | Miss | N/A | N/A | N/A | Mar 26, 2020 | N/A |
| Sep 30, 2019 | -$475.20 | -$475.20 | N/A | 0.00% | In line | N/A | 1 | N/A | Nov 12, 2019 | N/A |
| Jun 30, 2019 | -$475.20 | -$475.20 | N/A | 0.00% | In line | N/A | 1 | N/A | Aug 12, 2019 | N/A |
| Mar 31, 2019 | -$594.00 | -$475.20 | N/A | -25.00% | Miss | N/A | N/A | N/A | May 14, 2019 | $21000 |
| Dec 31, 2018 | -$66.00 | -$72.60 | N/A | +9.09% | Beat | N/A | N/A | N/A | Mar 27, 2019 | $81000 |
| Sep 30, 2018 | -$2,019.60 | -$2,643.30 | N/A | +23.60% | Beat | N/A | N/A | N/A | Nov 14, 2018 | $57000 |
| Jun 30, 2018 | -$2,732.40 | -$3,504.61 | N/A | +22.03% | Beat | N/A | N/A | N/A | Aug 14, 2018 | $58000 |
| Mar 31, 2018 | -$49.23 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | May 10, 2018 | $23000 |
| Dec 31, 2017 | -$4,989.61 | -$5,702.41 | N/A | +12.50% | Beat | N/A | N/A | N/A | Mar 26, 2018 | $15000 |
| Sep 30, 2017 | -$6,534.01 | -$6,534.01 | N/A | 0.00% | In line | N/A | N/A | N/A | Nov 8, 2017 | N/A |
| Jun 30, 2017 | -$6,444.91 | -$6,534.01 | N/A | +1.36% | Beat | N/A | N/A | N/A | Aug 10, 2017 | N/A |
| Mar 31, 2017 | -$7,128.01 | -$6,534.01 | N/A | -9.09% | Miss | N/A | N/A | N/A | May 11, 2017 | N/A |
| Dec 31, 2016 | -$3,960.00 | -$1,518.00 | N/A | -160.87% | Miss | N/A | N/A | N/A | Mar 30, 2017 | $19000 |
Estimates made before a stock split are shown on the same share basis as the reported EPS.
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$1.45, after -$7.54 the year before. It was -$46,596.06 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$1.45 | N/A |
| Dec 31, 2024 | -$7.54 | N/A |
| Dec 31, 2023 | -$15.74 | N/A |
| Dec 31, 2022 | -$90.90 | N/A |
| Dec 31, 2021 | -$55.40 | N/A |
| Dec 31, 2020 | -$125.53 | N/A |
| Dec 31, 2019 | -$2,087.64 | N/A |
| Dec 31, 2018 | -$4,867.23 | N/A |
| Dec 31, 2017 | -$25,096.54 | N/A |
| Dec 31, 2016 | -$46,596.06 | N/A |
Frequently Asked Questions About PHIO
When is Phio Pharmaceuticals's next earnings date?
Phio Pharmaceuticals's next earnings report is expected for Mar 3, 2027.
Did PHIO beat earnings estimates last quarter?
Phio Pharmaceuticals reported EPS of -$0.36 for the quarter ended Sep 30, 2026, in line with the -$0.36 estimate.
What EPS do analysts expect from PHIO next quarter?
The consensus EPS estimate for Phio Pharmaceuticals for the quarter ending Dec 31, 2026 is -$0.39 from 4 analysts, with estimates from -$0.39 to -$0.39.
How often does PHIO beat earnings estimates?
Phio Pharmaceuticals beat the EPS estimate in 3 of the 8 most recent quarters that had an estimate, with an average surprise of +11.12%.
PHIO pages: Overview, Earnings, Forecast, Financials, Competitors